Literature DB >> 17188586

Rat plasma proteomics: effects of abundant protein depletion on proteomic analysis.

Thomas Linke1, Sundari Doraiswamy, Earl H Harrison.   

Abstract

The proteomic analysis of plasma and serum samples represents a formidable challenge due to the presence of a few highly abundant proteins such as albumin and immunoglobulins. Detection of low abundance protein biomarkers requires therefore either the specific depletion of high abundance proteins with immunoaffinity columns and/or optimized protein fractionation methods based on charge, size or hydrophobicity. Here we describe the depletion of seven abundant rat plasma proteins with an immunoaffinity column with coupled antibodies directed against albumin, IgG, transferrin, IgM, haptoglobin, fibrinogen and alpha1-anti-trypsin. The IgY-R7-LC2 (Beckman Coulter) column showed high specificity for the targeted proteins and was able to efficiently remove most of the albumin, IgG and transferrin from rat plasma samples as judged by Western blot analysis. Depleted rat plasma protein samples were analyzed by SELDI-TOF MS, 2D SDS-PAGE and 2D-LC and compared to non-depleted plasma samples as well as to the abundant protein fraction that was eluted from the immunoaffinity column. Analysis of the depleted plasma protein fraction revealed improved signal to noise ratios, regardless of which proteomic method was applied. However, only a small number of new proteins were observed in the depleted protein fraction. Immunoaffinity depletion of abundant plasma proteins results in the significant dilution of the original sample which complicates subsequent analysis. Most proteomic approaches require specialized sample preparation procedures during which significant losses of less abundant proteins and potential biomarkers can occur. Even though abundant protein depletion reduces the dynamic range of the plasma proteome by about 2-3 orders of magnitude, the difference between medium-abundant and low abundant plasma proteins is still in the range of 7-8 orders of magnitude and beyond the dynamic range of current proteomic technologies. Thus, exploring the plasma proteome in greater detail remains a daunting task.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17188586     DOI: 10.1016/j.jchromb.2006.11.051

Source DB:  PubMed          Journal:  J Chromatogr B Analyt Technol Biomed Life Sci        ISSN: 1570-0232            Impact factor:   3.205


  15 in total

1.  New serum biomarkers for detection of esophageal carcinoma using Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry.

Authors:  Renyong Guo; Chunqin Pan; Jianmin Shen; Chibo Liu
Journal:  J Cancer Res Clin Oncol       Date:  2010-05-21       Impact factor: 4.553

2.  A method for isolation and identification of urinary biomarkers in patients with diabetic nephropathy.

Authors:  Wayne G Fisher; Jessica E Lucas; Uzma F Mehdi; Danna W Qunibi; Harold R Garner; Kevin P Rosenblatt; Robert D Toto
Journal:  Proteomics Clin Appl       Date:  2011-12       Impact factor: 3.494

3.  A comparison of protein extraction methods suitable for gel-based proteomic studies of aphid proteins.

Authors:  M Cilia; T Fish; X Yang; M McLaughlin; T W Thannhauser; S Gray
Journal:  J Biomol Tech       Date:  2009-09

4.  Depletion of plasma albumin for proteomic analysis of Bothrops jararaca snake plasma.

Authors:  Karen de Morais-Zani; Kathleen Fernandes Grego; Aparecida Sadae Tanaka; Anita Mitico Tanaka-Azevedo
Journal:  J Biomol Tech       Date:  2011-07

5.  Alterations in protein regulators of neurodevelopment in the cerebrospinal fluid of infants with posthemorrhagic hydrocephalus of prematurity.

Authors:  Diego M Morales; R Reid Townsend; James P Malone; Carissa A Ewersmann; Elizabeth M Macy; Terrie E Inder; David D Limbrick
Journal:  Mol Cell Proteomics       Date:  2011-12-20       Impact factor: 5.911

6.  Comparative plasma proteomic studies of pulmonary TiO2 nanoparticle exposure in rats using liquid chromatography tandem mass spectrometry.

Authors:  Megan M Maurer; Gregory C Donohoe; Hossein Maleki; Jinghai Yi; Carroll McBride; Timothy R Nurkiewicz; Stephen J Valentine
Journal:  J Proteomics       Date:  2015-09-14       Impact factor: 4.044

7.  High abundant protein removal from rodent blood for biomarker discovery.

Authors:  Dominik R Haudenschild; Angela Eldridge; Pamela J Lein; Brett A Chromy
Journal:  Biochem Biophys Res Commun       Date:  2014-12-05       Impact factor: 3.575

8.  Development of different analysis platforms with LC-MS for pharmacokinetic studies of protein drugs.

Authors:  Qiaozhen Lu; Xiaoyang Zheng; Thomas McIntosh; Hugh Davis; Jennifer F Nemeth; Chuck Pendley; Shiaw-Lin Wu; William S Hancock
Journal:  Anal Chem       Date:  2009-11-01       Impact factor: 6.986

9.  Proteomic analysis of mare follicular fluid during late follicle development.

Authors:  Somayyeh Fahiminiya; Valérie Labas; Stéphane Roche; Jean-Louis Dacheux; Nadine Gérard
Journal:  Proteome Sci       Date:  2011-09-17       Impact factor: 2.480

10.  An automated plasma protein fractionation design: high-throughput perspectives for proteomic analysis.

Authors:  Claudia Boccardi; Silvia Rocchiccioli; Antonella Cecchettini; Alberto Mercatanti; Lorenzo Citti
Journal:  BMC Res Notes       Date:  2012-11-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.